Literature DB >> 9598883

Evaluation of a modified needle for small joint biopsies.

T K Arayssi1, H R Schumacher.   

Abstract

OBJECTIVE: To assess the value of a new short biopsy needle modified from the Parker-Pearson needle in obtaining adequate synovial tissue from small joints.
METHODS: The short needle is 2.5 cm in length with a repositioned hooked biopsy notch closer to the end of the needle to allow better specimen retrieval. It can be used to obtain synovial biopsies from small joints of the hand using the usual arthrocentesis approaches.
RESULTS: Ten patients underwent 12 synovial biopsies with a success rate of 92%. No complications from the procedure were observed. Samples obtained were adequate for a variety of studies including synovial histopathological evaluation, electron microscopy, and DNA extraction.
CONCLUSION: The new modified short needle expands the spectrum of joints that can be biopsied for diagnostic and research purposes in an outpatient setting.

Entities:  

Mesh:

Year:  1998        PMID: 9598883

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  A randomised controlled trial of the reciprocating syringe in arthrocentesis.

Authors:  H T Draeger; J M Twining; C R Johnson; S C Kettwich; L G Kettwich; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  2005-12-08       Impact factor: 19.103

2.  Arthroscopic synovial biopsy in definitive diagnosis of joint diseases: An evaluation of efficacy and precision.

Authors:  Onis Singhal; Viplesh Kaur; Shivani Kalhan; Manish Kumar Singhal; Anshu Gupta; Yv Machave
Journal:  Int J Appl Basic Med Res       Date:  2012-07

3.  Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure.

Authors:  Carlo Alberto Scirè; Oscar Epis; Veronica Codullo; Frances Humby; Patrizia Morbini; Antonio Manzo; Roberto Caporali; Costantino Pitzalis; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.